Male Breast Cancer Terminated Phase 2 Trials for Triapine (DB11940)

IndicationStatusPhase
DBCOND0028546 (Male Breast Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT000958883-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast CancerTreatment